Fuzionaire Radioisotope Technologies K.K. and Nihon Medi-Physics Enter Feasibility Study Agreement
Press release content from Business Wire. The AP news staff was not involved in its creation. Fuzionaire Radioisotope Technologies K.K. and Nihon Medi-Physics Enter Feasibility Study Agreement January 26, 2021 GMT TOKYO--(BUSINESS WIRE)--Jan 26, 2021-- Fuzionaire Radioisotope Technologies K.K. (“FRIT”) today announced that it has entered into a feasibility study agreement with Nihon Medi-Physics Co., Ltd. (“NMP”), a leading radiopharmaceutical company in Japan, engaged in R&D, manufacturing, and distribution. Founded in 2019, FRIT is a joint venture between radiopharmaceutical compani...
Source: apnews.com